| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.50▲ | 1.50▼ | 1.50▼ | 1.51▼ | 1.48▲ |
| MA10 | 1.50▼ | 1.50▼ | 1.51▼ | 1.49▼ | 1.42▲ |
| MA20 | 1.50▼ | 1.51▼ | 1.50▼ | 1.49▼ | 1.77▼ |
| MA50 | 1.50▼ | 1.50▲ | 1.50▲ | 1.46▲ | 2.39▼ |
| MA100 | 1.50▼ | 1.49▲ | 1.50▲ | 1.79▼ | 3.54▼ |
| MA200 | 1.50▲ | 1.50▲ | 1.50▲ | 2.21▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.001▼ | -0.001▼ | 0.003▲ | 0.014▲ |
| RSI | 48.146▼ | 48.633▼ | 49.452▼ | 49.437▼ | 39.434▼ |
| STOCH | 25.000 | 45.000 | 26.667 | 56.424 | 59.359 |
| WILL %R | -50.000 | -80.000▼ | -80.000▼ | -60.976 | -46.027 |
| CCI | -81.159 | -111.111▼ | -123.333▼ | 18.820 | -27.014 |
|
Tuesday, November 03, 2026 12:16 PM
The study at the TCT conference in San Diego showed Boston Scientific's Watchman FLX Pro could allow for simpler blood thinner regimens.
|
|
Monday, November 02, 2026 11:02 AM
Boston Scientific Corporation (NYSE: BSX) today announced positive six-month primary endpoint results from the SIMPLAAFY randomized controlled trial of the WATCHMAN FLX™ Pro Left Atrial Appendage ...
|
|
SIMPLAAFY study of the WATCHMAN FLX Pro Left Atrial Appendage Closure Device meets primary endpoints
Monday, November 02, 2026 06:02 AM
Caution: Aspirin alone or reduced dose NOAC alone following LAAC with the WATCHMAN FLX Pro LAAC Device is an investigational post-implant drug regimen.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 06/11/26 | 1.52 | 1.54 | 1.48 | 1.48 | 230,986 |
| 05/11/26 | 1.52 | 1.54 | 1.48 | 1.52 | 246,160 |
| 04/11/26 | 1.50 | 1.51 | 1.47 | 1.51 | 228,800 |
| 03/11/26 | 1.52 | 1.52 | 1.47 | 1.50 | 207,995 |
| 02/11/26 | 1.46 | 1.55 | 1.45 | 1.53 | 210,180 |
| 30/10/26 | 1.46 | 1.5099 | 1.44 | 1.46 | 97,274 |
| 29/10/26 | 1.49 | 1.54 | 1.47 | 1.47 | 179,759 |
| 28/10/26 | 1.47 | 1.48 | 1.40 | 1.47 | 178,806 |
| 27/10/26 | 1.51 | 1.55 | 1.45 | 1.45 | 208,427 |
| 26/10/26 | 1.52 | 1.56 | 1.48 | 1.49 | 76,388 |
|
|
||||
|
|
||||
|
|